Search for: "Allergan, Inc." Results 221 - 240 of 385
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2013, 4:33 pm
On May 1, the US Court of Appeals for the Federal Circuit issued an interesting, yet controversial, ruling in Allergan Inc. v Sandoz Inc. et Al., examining obviousness in the context of a combination ophthalmic drug treatment. [read post]
1 May 2013, 9:59 pm by Patent Docs
By Andrew Williams -- Can a method of treatment claim be inherent in the prior art if neither the formulation nor the method of using the formulation twice a day were in the prior art? [read post]
9 Apr 2013, 7:23 am by Kristin Barlett
., holding that a derivative suit against Botox-maker Allergan, Inc. should be dismissed because Allergan had already secured a judgment in its favor in a nearly identical suit in California. [read post]
13 Mar 2013, 8:34 am by Mandour & Associates
IPNews® - Allergan, Inc. was granted partial summary judgment against Cosmetic Alchemy, LLC for inducing its customers to infringe Allergan’s patents that cover its popular eyelash growth drug Latisse. [read post]
30 Jan 2013, 8:22 am by Mandour & Associates
Barr Laboratories, Inc. and Sandoz, Inc. were found by the lower court to not have sufficiently proven their claims that Allergan’s patent was invalid due to prior art and obviousness. [read post]
7 Sep 2012, 3:23 pm by Bexis
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]
18 Jul 2012, 11:03 pm by FDABlog HPM
Allergan Inc., is a qui tam alleging federal and state false claims action violations arising out of average manufacturer price (“AMP”) reporting. [read post]